We are live on
!
Find out more
NFT
Nan Fung Trinity Portfolio holdings
AUM
$1.01B
1-Year Est. Return
64.38%
This Fund
S&P 500
This Quarter
Est. Return
-12.71%
1 Year Est. Return
+64.38%
3 Year Est. Return
+82.31%
5 Year Est. Return
+69.52%
10 Year Est. Return
–
AUM
$310M
AUM Growth
-$49.5M
(-14%)
Cap. Flow
-$83.2K
Cap. Flow
% of AUM
-0.03%
Top 10 Holdings %
Top 10 Hldgs %
88.33%
Holding
23
New
–
Increased
15
Reduced
–
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$7.1M |
| 2 |
Baidu
BIDU
|
+$6.49M |
| 3 |
Carnival Corporation Ltd
CCL
|
+$4.19M |
| 4 |
United Airlines
UAL
|
+$3.47M |
| 5 |
Trip.com Group
TCOM
|
+$202K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$18M |
| 2 |
General Motors
GM
|
+$3.27M |
| 3 |
CRHC
Cohn Robbins Holdings Corp.
CRHC
|
+$1.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 43.08% |
| 2 | Consumer Discretionary | 29.71% |
| 3 | Industrials | 11.92% |
| 4 | Financials | 4.17% |
| 5 | Technology | 2.8% |
Similar funds
WA
GA
MAM
AG
BCM
EPAM
COI
CT
Nan Fung Trinity's Q3 2022 Portfolio in Review
As of Q3 2022, Nan Fung Trinity held 23 positions worth $310M, down 14% from $360M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
Nan Fung Trinity's Q3 2022 filing shows 15 increased and 3 closed positions. The largest sale was BioMarin Pharmaceuticals, an estimated $18M.
By sector, the portfolio is most concentrated in Communication Services at 43% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Nan Fung Trinity added most to Alibaba in Q3 2022, an estimated $7.1M increase.
- Nan Fung Trinity fully exited BioMarin Pharmaceuticals in Q3 2022, selling an estimated $18M.
- Nan Fung Trinity's ten largest holdings make up 88% of its $310M portfolio in Q3 2022.
- Nan Fung Trinity opened 0 new positions and closed 3 in Q3 2022.
- Nan Fung Trinity's portfolio value fell 14% quarter-over-quarter to $310M.
Based on Nan Fung Trinity's 13F filing for Q3 2022, filed 26 Oct 2022.